NEW YORK (GenomeWeb) – Abbott reported Wednesday morning that first quarter sales in its Diagnostics business grew 4 percent year over year, driven by strong growth in core laboratory and point-of-care sales.

For the three months ended March 31, Abbott reported overall Q1 revenues of $6.34 billion, up 30 percent on a reported basis from Q1 last year, and up 3 percent on a comparable basis accounting for the acquisition of St. Jude Medical closed in January. The company beat the consensus Wall Street estimate of $6.15 billion.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.